Mesoblast (ASX: MSB) – Phase 3 CLBP Trial Reaches Major Milestone
Mesoblast Limited has reached a critical juncture in its development timeline, completing patient treatment in the MSB-DR004 Phase 3 trial for...
Mesoblast Limited has reached a critical juncture in its development timeline, completing patient treatment in the MSB-DR004 Phase 3 trial for...
IRESS Limited delivered a pivotal 1H26 performance that underscores a fundamental shift in the company's earnings quality. While revenue growth...
Iress Limited's first-half results reveal a company firing on multiple fronts, with Cash EBITDA surging 47.1% to $61.1m while margins expanded 740...
Iress Limited delivered a perplexing but ultimately encouraging half-year result that challenges a straightforward reading of the numbers. Revenue...
Ampol Limited has scheduled its half-year 2026 results announcement for Monday, 24 August 2026, with a management briefing commencing at 10:00 AM...
New Hope Corporation delivered results that surpassed full-year guidance on both production and sales volumes for the 2026 financial year. Saleable...
JB Hi-Fi Limited presented its FY26 full year results on 17 August 2026, positioning the group as the number one player in the Australian consumer...
Growthpoint Properties Australia has delivered FY26 Funds From Operations (FFO) at the upper end of guidance, demonstrating disciplined asset and...
Growthpoint Properties Australia delivered funds from operations of $177.6 million in FY26, achieving 23.5 cents per security and landing near the...
The consortium comprising Amwins Group, Dragoneer Investment Group, and Kohlberg Kravis Roberts has reconfirmed its commitment to acquire Steadfast...
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000